Charlene Graham
Recovery Sales Specialist @US WorldMeds
Signup · Get unlimited contacts
WORK HISTORY
Recovery Sales Specialist @US WorldMeds
Nashville, TN
I was recruited to launch a branded drug in a generic market and drive prescription growth for Lucemyra (only FDA approved non opioid /non addictive treatment for opioid withdrawal) by calling on and building strong and ongoing relationships with Addiction Specialists, Treatment Centers, MAT clinics, PHPs, IOPs, Detox facilities, and Pain Management Clinics. Covered multiple territories including Middle & East Tennessee, Western Kentucky, North Georgia, and Austin, Texas. • Finished Q1 2024 with total prescription volume at approximately 115% of quota.• Won 2023 Spot Award for regional impact and added 46 new prescribers for the year.• Achieved 2023 results of 131% of quota in Q1, 145% of quota in Q2, and 123% of quota in Q3.• Produced total prescription volume increase of 45% in 2023, ranking #4 in the Southeast region.• Won 2022 Spot Award, generated 69.1% territory growth, and added 49 new unique prescribers.• Finished 2021 with best quarterly results of 142.9% in Q2 and 120.6% in Q4 to goal.• Overcame managed care coverage challenges, finishing #6 in SE Region in 2018 and #22 in US for 2019.• Earned compliments from managers for drive/determination and ability to build relationships as a “trusted advisor” to prescribers, DONs, Clinical Directors, Medical Directors, and nursing staff in the addiction recovery.
EDUCATION
Mississippi University for Women
Bachelor of Science
ABOUT CHARLENE GRAHAM
My success as a top performer in the specialty pharmaceutical and addiction/recovery markets can be demonstrated by winning awards (3-time President’s Club & Pinnacle Club Awards) and ranking as high as #1 in the US during my career with US WorldMeds, Assertio/Depomed, Quintiles, and Wyeth Pharmaceuticals. In my most recent position since 2018 with US WorldMeds, I ranked as high as #6 in the region and achieved up to 145% of quota by calling on and selling to Addiction Specialists, Treatment Centers, MAT clinics, PHPs, IOPs, Detox Facilities, and Pain Management Clinics. My ability to exceed expectations and drive prescription growth in any market can be demonstrated by: • Finished Q1 2024 with total prescription volume at approximately 115% of quota. • Won 2023 Spot Award for regional impact and added 46 new prescribers for the year. • Won 2022 Spot Award, generated 69.1% territory growth, and added 49 new unique prescribers. These results have been based on my strengths for clinical, educational & relationship-based selling; launching new products in highly competitive markets; passion for addiction/recovery patient care; prospecting for new sales opportunities; strong attention to detail & follow-through; proven success selling in dynamic start-up environments; dedicated work ethic & commitment to excellence; and reputation for team-oriented collaboration skills. All the experience I\'ve gained throughout my career gives me the confidence to drive sales growth in any healthcare market, adapt quickly to new medications and disease states, and communicate value to prescribers.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.